MindMed to Participate in September Investor Conferences
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on brain health disorders, has announced its participation in three major investor conferences in September 2024. The company will be involved in:
1. A panel discussion on psychedelics in psychiatry at the H.C. Wainwright Global Investment Conference on September 10.
2. A fireside chat at Baird's Global Healthcare Conference on September 11.
3. Another fireside chat at the Cantor Global Healthcare Conference on September 17.
All events will take place in New York, NY. Audio webcasts and replays of available presentations will be accessible on MindMed's Investor Relations website for up to 90 days after each event, providing investors with extended access to the company's insights and updates.
MindMed (NASDAQ: MNMD), un'azienda biofarmaceutica in fase clinica focalizzata sui disturbi della salute mentale, ha annunciato la sua partecipazione a tre importanti conferenze per investitori a settembre 2024. L'azienda sarà coinvolta in:
1. Una discussione di panel su psichedelici in psichiatria durante l'H.C. Wainwright Global Investment Conference il 10 settembre.
2. Un incontro informale alla Global Healthcare Conference di Baird l'11 settembre.
3. Un altro incontro informale alla Cantor Global Healthcare Conference il 17 settembre.
Tutti gli eventi si svolgeranno a New York, NY. I webcast audio e le repliche delle presentazioni disponibili saranno accessibili sul sito web delle Relazioni con gli Investitori di MindMed per un massimo di 90 giorni dopo ciascun evento, fornendo agli investitori un accesso prolungato alle intuizioni e agli aggiornamenti dell'azienda.
MindMed (NASDAQ: MNMD), una compañía biofarmacéutica en etapa clínica enfocada en trastornos de salud mental, ha anunciado su participación en tres importantes conferencias de inversores en septiembre de 2024. La compañía estará involucrada en:
1. Una discusión en panel sobre psicodélicos en psiquiatría en la H.C. Wainwright Global Investment Conference el 10 de septiembre.
2. Una charla informal en la Conferencia Global de Salud de Baird el 11 de septiembre.
3. Otra charla informal en la Conferencia Global de Salud de Cantor el 17 de septiembre.
Todos los eventos se llevarán a cabo en Nueva York, NY. Las transmisiones de audio y las repeticiones de las presentaciones disponibles serán accesibles en el sitio web de Relaciones con Inversores de MindMed durante un máximo de 90 días después de cada evento, proporcionando a los inversores un acceso prolongado a las percepciones y actualizaciones de la compañía.
MindMed (NASDAQ: MNMD)는 뇌 건강 장애에 초점을 맞춘 임상 단계의 생명공학 회사로, 2024년 9월에 세 가지 주요 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 다음과 같은 일정으로 참가합니다:
1. 9월 10일 H.C. Wainwright Global Investment Conference에서 정신의학에서의 사이키델릭스에 대한 패널 토론.
2. 9월 11일 Baird의 글로벌 헬스케어 컨퍼런스에서의 대화.
3. 9월 17일 Cantor 글로벌 헬스케어 컨퍼런스에서의 또 다른 대화.
모든 이벤트는 뉴욕에서 개최됩니다. 오디오 웹캐스트와 각 이벤트 후 최대 90일 동안 이용 가능한 발표 재생은 MindMed의 투자자 관계 웹사이트에서 접근할 수 있어 투자자들에게 회사의 통찰력과 업데이트에 대한 연장된 접근을 제공합니다.
MindMed (NASDAQ: MNMD), une entreprise bio-pharmaceutique en phase clinique axée sur les troubles de la santé mentale, a annoncé sa participation à trois grandes conférences d'investisseurs en septembre 2024. L'entreprise sera impliquée dans :
1. Une discussion en panel sur les psychédéliques en psychiatrie lors de la H.C. Wainwright Global Investment Conference le 10 septembre.
2. Une discussion informelle à la Global Healthcare Conference de Baird le 11 septembre.
3. Une autre discussion informelle à la Cantor Global Healthcare Conference le 17 septembre.
Tous les événements se dérouleront à New York, NY. Les webinaires audio et les rediffusions des présentations disponibles seront accessibles sur le site des Relations avec les Investisseurs de MindMed jusqu'à 90 jours après chaque événement, offrant aux investisseurs un accès prolongé aux idées et aux mises à jour de l'entreprise.
MindMed (NASDAQ: MNMD), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Gehirngesundheitsstörungen konzentriert, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird sich an Folgendem beteiligen:
1. Eine Podiumsdiskussion über Psychedelika in der Psychiatrie auf der H.C. Wainwright Global Investment Conference am 10. September.
2. Ein informelles Gespräch auf der Global Healthcare Conference von Baird am 11. September.
3. Ein weiteres informelles Gespräch auf der Cantor Global Healthcare Conference am 17. September.
Alle Veranstaltungen finden in New York, NY statt. Audio-Webcasts und Wiederholungen der verfügbaren Präsentationen werden auf der Investor Relations-Website von MindMed bis zu 90 Tage nach jedem Event zugänglich sein, um Investoren einen verlängerten Zugang zu den Erkenntnissen und Neuigkeiten des Unternehmens zu bieten.
- None.
- None.
-
H.C. Wainwright 26th Annual Global Investment Conference
- Format: Panel
- Panel Title: Psychedelics in Psychiatry: Breaking New Ground in Mood Disorders
- Date and Time: Tuesday, September 10, 2024 at 3:00 PM ET
-
Location:
New York, NY
-
Baird’s 2024 Global Healthcare Conference
- Format: Fireside Chat
- Date and Time: Wednesday, September 11, 2024 at 12:15 PM ET
-
Location:
New York, NY - Webcast Link: Baird’s 2024 Global Healthcare Conference
-
2024 Cantor Global Healthcare Conference
- Format: Fireside Chat
- Date and Time: Tuesday, September, 17 at 10:20 AM ET
-
Location:
New York, NY - Webcast Link: 2024 Cantor Global Healthcare Conference
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.
About MindMed
MindMed is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240904981833/en/
For Media: media@mindmed.co
For Investors: ir@mindmed.co
Source: Mind Medicine Inc.
FAQ
What investor conferences will MindMed (MNMD) participate in during September 2024?
What type of presentation will MindMed (MNMD) give at the H.C. Wainwright conference?
Will there be webcasts available for MindMed's (MNMD) conference presentations?
Where will the September 2024 investor conferences featuring MindMed (MNMD) be held?
